Adeka (4401) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
10 Mar, 2026Executive summary
Net sales for the nine months ended December 31, 2025, were ¥296,791 million, up 0.1% year-over-year.
Operating profit decreased by 2.6% to ¥29,307 million, while ordinary profit rose 2.4% to ¥30,395 million.
Profit attributable to owners of parent increased 3.4% to ¥19,855 million.
Comprehensive income surged 51.8% year-over-year to ¥36,307 million.
Financial highlights
Gross profit for the period was ¥84,752 million, up from ¥84,034 million year-over-year.
Basic earnings per share rose to ¥196.85 from ¥188.42 year-over-year.
Total assets increased to ¥558,400 million from ¥543,118 million as of March 31, 2025.
Equity-to-asset ratio improved to 55.4% from 54.6% at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast revised to ¥415,000 million, up 1.9% year-over-year.
Operating and ordinary profit both forecast at ¥41,500 million, up 1.2% and 5.5% respectively.
Profit attributable to owners of parent projected at ¥25,500 million, up 1.9% year-over-year.
Annual dividend forecast raised to ¥104 per share.
Latest events from Adeka
- Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 202610 Mar 2026 - Life Science strength drove profit growth, offsetting Chemicals and Food Products weakness.4401
Q2 202610 Mar 2026 - Profits and sales grew, led by Chemicals and Food Products, with raised outlook and Life Science loss.4401
Q1 202510 Mar 2026 - Strategic investments and innovation in semiconductor materials target rapid global growth.4401
Investor presentation10 Mar 2026 - 3Q FY2024 saw higher sales and profits, driven by Chemicals and global expansion.4401
Q3 202510 Mar 2026 - Strong 1H FY2024 results and Chemicals growth led to higher guidance and dividend forecasts.4401
Q2 202510 Mar 2026 - Record sales and profit growth driven by Chemicals, with continued expansion and higher dividends forecast.4401
Q4 202510 Mar 2026